A new drug that blocks cancer's escape route from chemotherapy could
be used to treat deadly lung and pancreatic cancers, new research
reports.
Scientists have shown in human cancer cells and in mice that the
drug - discovered at The Institute of Cancer Research, London, boosts
the effectiveness of conventional chemotherapy.
The drug, known as CCT245737, is scheduled to begin first-in-human
clinical trials in patients with lung and pancreatic cancers - two
cancers with low survival rates that continue to resist currently
available treatments.
The new study is published in the journal Oncotarget, and was funded by Cancer Research UK and Sareum Limited.
No comments:
Post a Comment